Image

Indonesia At-Home Testing Kits Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Published Report
  • Apr 2022
  • Country Level
  • 350 Pages
  • No of Tables: 69
  • No of Figures: 42
  • Pharmaceutical
  • Published Report
  • Apr 2022
  • Country Level
  • 350 Pages
  • No of Tables: 69
  • No of Figures: 42

Indonesia At-home Testing Kits Market, By Test Type (Pregnancy Test Kits, Other At-Home Test Kits, Narcotic Test Kits, HIV Test Kits & Fertility Test Kits), Type of User (High Class, Middle Class & Lower Class), Type of Buyer (Pregnancy Test Kits, Other At-Home Test Kits, Narcotic Test Kits, HIV Test Kits & Fertility Test Kits), Process Location (At-Home & At-Home Lab Tests (Digital Results), Age (Adult, Geriatric & Pediatric), Brands (Pregnancy Test, Other At-Home Test, Narcotic Test, HIV Test, and Fertility Test), Distribution Channel (Institutional Buyer & Retail/Branded Sales) Industry Trends and Forecast to 2029.

 Indonesia Market Analysis and Insights 

At-home testing kits mean testing instruments that help a person perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of diabetic patients. At-home tests are very convenient to perform with comfort at home and are available at a very affordable rate.

Indonesia At-Home Testing kits market

Self-tests are usually the advanced versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by the common person. Their processes, packaging, and instructions have been simplified to guide the person through the steps of taking a test. Various at-home test kits are available including HIV tests, pregnancy tests, diabetes, ovulation test, and infectious diseases such as malaria, COVID-19, and others. For performing these rapid at-home tests, blood, urine, and oral fluid can be taken as a sample

Indonesia at-home testing kits market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 4.6% in the forecast period of 2022 to 2029 and is expected to reach IDR 16, 81,367.36 million by 2029 from IDR 10, 13,289.31 million in 2021.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020

Quantitative Units

Revenue in IDR Million

Segments Covered

By Test Type (Pregnancy Test Kits, Other At-Home Test Kits, Narcotic Test Kits, HIV Test Kits & Fertility Test Kits), Type of User (High Class, Middle Class & Lower Class ), Type of Buyer (Pregnancy Test Kits, Other At-Home Test Kits, Narcotic Test Kits, HIV Test Kits & Fertility Test Kits), Process Location (At-Home & At-Home Lab Tests (Digital Results), Age (Adult, Geriatric & Pediatric), Brands (Pregnancy Test, Other At-Home Test, Narcotic Test, HIV Test & Fertility Test), Distribution Channel (Institutional Buyer & Retail/Branded Sales)

Countries Covered

Indonesia

Market Players Covered

The major companies which are dealing in the market are Abbott, PT. Danpac Pharma, Orient Gene, Siemens Healthcare GmbH, Medtronic, BD, B. Braun Melsungen AG, Quidel Corporation, NIPRO, F. Hoffmann-La Roche Ltd., bioMérieux SA, EGENS GROUP, DKT INTERNATIONAL, Clearblue (A subsidiary of SPD Swiss Precision Diagnostics GmbH) and ACON Laboratories, Inc. among others

At-home Testing Kits Market Dynamics

Drivers

  • Growing adoption of self-testing kits

As awareness has grown regarding several products, this behaviour has changed and has turned the trend. Nowadays, people prefer to get their basic tests done using test kits at home before visiting a doctor. This has become even more prominent due to this pandemic as people are adopting more self-help testing kits due to several restrictions in place. It has turned out to be a boon in disguise for both hospitals as patients as hospitals are already stretched thin and can fully focus on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees. It has become extremely convenient for consumers as they can know the results of their tests quickly just at their fingertips.

  • Easy availability of self-testing kits at pharmacies

At-home or self-testing kits are easily available at pharmacies, and it has become extremely easy to procure them. Various medical companies are venturing into this space as they rapidly manufacture self-test kits. This widespread availability can also be attributed to online pharmacies' medical start-ups, making availability easier by clicking a button. In addition, these self-testing kits are available without any prescription

  • Increasing prevalence of chronic diseases

The prevalence of the chronic disease is briskly increasing across the globe. According to the Indonesian Sample Registration System, the ten most common diseases found in Indonesia in 2014 were stroke (21.1%), heart disease (12.9%), diabetes mellitus (6.7%), tuberculosis (5.7%), complications of high blood pressure (5.3%), chronic lung disease (4.9%), liver disease (2.7%), traffic accidents (2.6%), pneumonia (2.1%), and combined diarrhoea and gastroenteritis due to infection (1.9%). Thus, the high prevalence of chronic diseases will be a major driver for the at-home testing kits market as it can provide better monitoring and diagnosis of disease

Opportunities

  • Advent of advanced technologies

The technological experts are continuously working towards the advancements of the rapid testing kits to deliver accurate and reliable results to the person who is not a healthcare professional and can understand the results independently.

Thus, advanced technologies such as artificial intelligence are creating lucrative opportunities for the healthcare industry, the companies are incorporating advanced technologies in at-home testing kits to make them more reliable and trustworthy to drive the market

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the at-home testing kits market in the forecast period of 2022-2029.

Indonesia At-Home Testing kits market

Restraints/Challenges

However, the inaccuracy of result with self-testing kits will impede the growth rate of at-home testing kits market. Additionally, stringent rules and regulations will further challenge the market in the forecast period mentioned above.

This at-home testing kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on at-home testing kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post COVID-19 Impact on At-Home Testing Kits Market

The COVID-19 has positively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. Hence the use of self-testing kits at households widely increased in the country population. People on large scale used the self-testing kits in the overall pandemic for the disease diagnosis and easy availability of such testing kits boost the market in positive way

Recent Development

  • In November 2020, Quidel Corporation has developed a rapid diagnostic test for the detection of COVID-19 and received Emergency Use Authorization (EUA) from the FDA for launching and marketing its Sofia 2 SARS Antigen FIA, a rapid point-of-care test for COVID-19. It will be used for ongoing pandemic and this will help the company to increase its sales and revenue

Indonesia At-home Testing Kits Market Scope

Indonesia at-home testing kits market is segmented into test type, type of user, type of buyer, process location, age, brands and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Test Type

  • Pregnancy Test Kits
  • Other At-Home Test Kits
  • Narcotic Test Kits
  • HIV Test Kits
  • Fertility Test Kits

On the basis of test type, the Indonesia at-home testing kits market is segmented into pregnancy test kits, other at-home test kits, narcotic test kits, HIV test kits and fertility test kits

Type of User

  • High Class
  • Middle Class
  • Lower Class

On the basis of type of user, the Indonesia at-home testing kits market is segmented into high class, middle class and lower class

Type of Buyer

  • Pregnancy Test Kits
  • Other At-Home Test Kits
  • Narcotic Test Kits
  • HIV Test Kits
  • Fertility Test Kits

On the basis of type of buyer, the Indonesia at-home testing kits market is segmented into pregnancy test kits, other at-home test kits, narcotic test kits, HIV test kits & fertility test kits

Process Location

  • At-Home
  • At-Home Lab Tests (Digital Results)

On the basis of process location, the Indonesia at-home testing kits market is segmented into at-home & at-home lab tests (digital results)

Age

  • Adult
  • Geriatric
  • Pediatric

On the basis of age, the Indonesia at-home testing kits market is segmented into adult, geriatric and pediatric

Brands

  • Pregnancy Test
  • Other At-Home Test
  • Narcotic Test
  • HIV Test
  • Fertility Test

On the basis of brands, the Indonesia at-home testing kits market is segmented into pregnancy test, other at-home test, narcotic test, HIV test & fertility test

Distribution Channel

  • Institutional Buyer
  • Retail/ Branded Sales

Indonesia At-Home Testing kits market

On the basis of distribution channel, the Indonesia at-home testing kits market is segmented into institutional buyer & retail/branded sales

At-home Testing Kits Market Regional Analysis/Insights         

The at-home testing kits market is analysed and market size insights and trends are provided by country, test type, type of user, type of buyer, process location, age, brands and distribution channel as referenced above.

Indonesia dominates the at-home testing kits market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to implementing awareness programs regarding the self-testing kits and research and development in the advanced technologies for the testing kits in the Indonesia region further improves this market growth.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and At-Home Testing Kits Market Share Analysis

The at-home testing kits market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on at-home testing kits market.

Some of the major players operating in the at-home testing kits market are Abbott, PT. Danpac Pharma, Orient Gene, Siemens Healthcare GmbH, Medtronic, BD, B. Braun Melsungen AG, Quidel Corporation, NIPRO, F. Hoffmann-La Roche Ltd., bioMérieux SA, EGENS GROUP, DKT INTERNATIONAL, Clearblue (A subsidiary of SPD Swiss Precision Diagnostics GmbH), and ACON Laboratories, Inc. among others.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs. Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.

 


SKU-
Why Choose Us


Frequently Asked Questions

Indonesia At-Home Testing Kits Market to grow at a CAGR 4.6% by forecast 2029.
Indonesia At-Home Testing Kits Market value to reach IDR 16, 81,367.36 million by forecast 2029.
Indonesia region holds the largest share in the market.
Major players operating in the at-home testing kits market are Abbott, PT. Danpac Pharma, Orient Gene, Siemens Healthcare GmbH, Medtronic, BD, B. Braun Melsungen AG, Quidel Corporation, NIPRO, F. Hoffmann-La Roche Ltd., bioMérieux SA, EGENS GROUP, DKT INTERNATIONAL, Clearblue (A subsidiary of SPD Swiss Precision Diagnostics GmbH), and ACON Laboratories, Inc.